Development

A trial moves 40% of treated children below the obesity threshold

development2026-09-07

Claim

Novo Nordisk's STEP Young trial moved 40.4% of children aged six to eleven below the obesity threshold on semaglutide, against 0% on placebo.

Reported metric: 40.4% vs 0%

Reporting date: 2026-09-07 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to September 7, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to September 7, 2026

Actor

Novo Nordisk

Evidence for

Supersedes

A weight-loss drug extends mouse lifespan by nearly a hundred days

Referenced by

Cite or correct this record

Citation formatCitation text

A trial moves 40% of treated children below the obesity threshold
Innermost Loop KB — secondary record
Reporting date: 2026-09-07
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-09-07-forty-percent-of-children-moved-below-a-threshold
Claim: Novo Nordisk's STEP Young trial moved 40.4% of children aged six to eleven below the obesity threshold on semaglutide, against 0% on placebo.
Attributed sources:
- Welcome to September 7, 2026 — https://theinnermostloop.substack.com/p/welcome-to-september-7-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.